Ji-An Wang
Overview
Explore the profile of Ji-An Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Dai Q, Wang J, Xu L, Chen Q, Jin Y
World J Clin Cases
. 2024 Jun;
12(16):2881-2886.
PMID: 38899312
Background: Granulomatosis with polyangiitis (GPA) is one of the most prevalent forms of the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. GPA is characterized histologically by necrotizing granulomatous inflammation in addition to...
2.
Zhang Y, Gong Y, Tang Y, Bai Y, Yang K, Chen H, et al.
Dermatol Ther
. 2022 Jun;
35(8):e15657.
PMID: 35726636
Axillary osmidrosis (AO) and primary hyperhidrosis (PH) are common diseases, but there are still difficulties in treatment. Microwave therapy may become a new method. In order to evaluate long-time efficacy...
3.
Xu L, Song X, Zhang Y, Lin N, Wang J
J Med Case Rep
. 2021 Jun;
15(1):325.
PMID: 34167586
Background: Sjögren's syndrome is a common autoimmune disease that can involve the nervous system, but rarely both the central and peripheral. Long-term use of high-dose corticosteroids and immunosuppressants are the...
4.
Xu L, Song X, Dai Q, Guan T, Zhang Y, Lin N, et al.
Int Immunopharmacol
. 2021 Apr;
96:107574.
PMID: 33836367
Lupus cystitis (LC) is a rare manifestation of SLE, the diagnosis of LC is challenging, especially in the absence of other systemic manifestations or the obvious disease activity index of...
5.
Treichel A, Hamieh L, Nathan N, Tyburczy M, Wang J, Oyerinde O, et al.
Genet Med
. 2019 May;
21(11):2594-2604.
PMID: 31114024
Purpose: To determine if mosaic tuberous sclerosis complex (TSC) can be stratified into subtypes that correspond with prognosis and extent of disease. Methods: Next-generation sequencing of skin tumor and other...
6.
Pacheco-Rodriguez G, Steagall W, Samsel L, Dagur P, McCoy J, Tunc I, et al.
Chest
. 2019 Apr;
156(2):298-307.
PMID: 31034819
Background: Lymphangioleiomyomatosis (LAM) is a destructive metastasizing neoplasm of the lung characterized by proliferation of LAM cells in specialized lung nodules. LAM cells are characterized by expression of the prometastatic...
7.
Klover P, Thangapazham R, Kato J, Wang J, Anderson S, Hoffmann V, et al.
Elife
. 2017 Jul;
6.
PMID: 28695825
Increased mTORC1 signaling from inactivation is found in cancer and causes tuberous sclerosis complex (TSC). The role of mesenchymal-derived cells in TSC tumorigenesis was investigated through disruption of in craniofacial...
8.
Bongiorno M, Nathan N, Oyerinde O, Wang J, Lee C, Brown G, et al.
JAMA Dermatol
. 2017 Apr;
153(7):660-665.
PMID: 28445558
Importance: Patients with tuberous sclerosis complex (TSC) frequently develop collagenous connective tissue nevi. The prototypical lesion is a large shagreen patch located on the lower back, but some patients only...
9.
Nathan N, Tyburczy M, Hamieh L, Wang J, Brown G, Lee C, et al.
J Invest Dermatol
. 2016 Jan;
136(2):535-538.
PMID: 26824744
No abstract available.
10.
Nathan N, Wang J, Li S, Cowen E, Haughey M, Moss J, et al.
J Am Acad Dermatol
. 2015 Sep;
73(5):802-8.
PMID: 26365597
Background: Oral mechanistic target of rapamycin inhibitors have been shown to reduce visceral tumor volume in patients with tuberous sclerosis complex (TSC). Objective: We sought to evaluate the cutaneous response...